Terms: = Uterine cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
8 results:
1. The role of poly (ADP-ribose) glycohydrolase in phosphatase and tensin homolog deficiency endometrial cancer.
Sun Y; Shi Y; Liu H; Lv C; Zhang A
J Obstet Gynaecol Res; 2023 Apr; 49(4):1244-1254. PubMed ID: 36759425
[TBL] [Abstract] [Full Text] [Related]
2. Management and prognosis of Patients with Recurrent or Persistent/Progressive uterine Carcinosarcoma.
Tung HJ; Chiang CY; Chang WY; Wu RC; Huang HJ; Yang LY; Lin CY; Wang CC; Chao A; Lai CH
Curr Oncol; 2022 Oct; 29(10):7607-7623. PubMed ID: 36290878
[TBL] [Abstract] [Full Text] [Related]
3. [A nested case-control study on the relationship between red blood cell folate and the prognosis of low-grade cervical intraepithelial neoplasia].
Zhu JJ; Wang JT; Gong L; Ran ZX; Guo CY; Song L; Lyu YJ; Ding L
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Apr; 56(4):453-458. PubMed ID: 35488542
[No Abstract] [Full Text] [Related]
4. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
[TBL] [Abstract] [Full Text] [Related]
5. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
[TBL] [Abstract] [Full Text] [Related]
6. Thyroid transcription factor-1 (ttf-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus.
Ervine A; Leung S; Gilks CB; McCluggage WG
Histopathology; 2014 May; 64(6):840-6. PubMed ID: 24267480
[TBL] [Abstract] [Full Text] [Related]
7. A prospective cohort study to compare treatment results between 2 fractionation schedules of high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer.
Huang EY; Sun LM; Lin H; Lan JH; Chanchien CC; Huang YJ; Wang CY; Wang CJ
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):123-8. PubMed ID: 22672751
[TBL] [Abstract] [Full Text] [Related]
8. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
[TBL] [Abstract] [Full Text] [Related]
